Andromeda Capital’s Nu Skin NUS Stock Holding History

Andromeda Capital’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-629	Closed	-$52K	–	146
2014 Q1	$52K	Buy	+629	New	+$55.3K	﹤0.01%	107

Other funds holding NUS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ESG

Emerging Sovereign Group New York $252M AUM 22.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

EPCM

Eton Park Capital Management New York $2.28B AUM 33.59% 1-Year Est. Return

Andromeda Capital's NUS Position: Q2 2014 in Review

Andromeda Capital sold out of Nu Skin (NUS) in Q2 2014, closing a stake of 629 shares — an estimated $52K sold.

Andromeda Capital first reported a position in NUS in Q1 2014 and held it in 1 quarter. The position peaked at $52K in Q1 2014. 267 funds tracked by Wall St. Rank hold NUS as of Q2 2014.

Andromeda Capital reported no remaining Nu Skin position as of Q2 2014 after selling out during the quarter.
Andromeda Capital sold 629 Nu Skin shares in Q2 2014, an estimated $52K.
Andromeda Capital first reported a position in Nu Skin in Q1 2014 and held it in 1 quarter.
Andromeda Capital's Nu Skin position peaked at $52K in Q1 2014.
267 funds tracked by Wall St. Rank held Nu Skin as of Q2 2014.

Based on Andromeda Capital's 13F filing for Q2 2014, filed 14 Aug 2014.